Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,034.00
+2.00 (0.19%)
Jun 12, 2026, 1:44 PM IDT
Golden House Market Cap
Golden House has a market cap or net worth of 160.44 million as of June 12, 2026. Its market cap has decreased by -21.96% in one year.
Market Cap
160.44M
Enterprise Value
119.47M
Revenue
46.05M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,034.00
Market Cap Chart
Since March 30, 2006, Golden House's market cap has increased from 74.77M to 160.44M, an increase of 114.58%. That is a compound annual growth rate of 3.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 160.44M | 1.17% |
| Dec 31, 2025 | 158.58M | -55.97% |
| Dec 31, 2024 | 360.14M | 47.35% |
| Dec 31, 2023 | 244.41M | 50.96% |
| Dec 29, 2022 | 161.90M | -36.51% |
| Dec 30, 2021 | 255.00M | 16.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 117.68B |
| Danel (Adir Yeoshua) | 2.89B |
| Amal Holdings A.D. | 2.49B |
| BrainsWay | 1.73B |
| Bonus BioGroup | 381.98M |
| Geffen Residence & Renewal | 320.88M |
| Epitomee Medical | 206.47M |
| InterCure | 143.70M |